tirzepatide studies 2025 Impact of 1-Year Use on Glycemic and Metabolic Profile in Overweight to Obese People with Type 1 Diabetes: A Systematic Review and Meta-Analysis Rising use of GLP-1 medications
Description
A study of over 18,000 participants found that tirzepatide led to greater weight loss and improved blood sugar levels compared to semaglutide
The company also advertises a "365-Day Money-Back Guarantee" described as a "Weight Loss Warranty." According to the company's website, terms and conditions apply to this guarantee
Retatrutide 10mg Lyophilized powder First-in-class triple agonist targeting GIP, GLP-1, and glucagon receptors simultaneously, with early-phase results published in the New England Journal of Medicine
Prescribed and delivered
The reduction in UACR was most pronounced in participants with baseline UACR 30 mg/g
If your vial actually contains 10.87mg but you reconstitute assuming exactly 10mg, your actual concentration will be 10.87mg/ml instead of 10mg/ml
